<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2017.00661</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Non-canonical Glucocorticoid Receptor Transactivation of <italic>gilz</italic> by Alcohol Suppresses Cell Inflammatory Response</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Ng</surname> <given-names>Hang Pong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jennings</surname> <given-names>Scott</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Jack</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Molina</surname> <given-names>Patricia E.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nelson</surname> <given-names>Steve</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Wang</surname> <given-names>Guoshun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<uri xlink:href="http://frontiersin.org/people/u/430080"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Alcohol and Drug Abuse Center, Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center</institution>, <addr-line>New Orleans, LA</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Physiology, Louisiana State University Health Sciences Center</institution>, <addr-line>New Orleans, LA</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Medicine, Louisiana State University Health Sciences Center</institution>, <addr-line>New Orleans, LA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Jixin Zhong, Case Western Reserve University, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Shanzhong Gong, University of Texas at Austin, United States; Yanlin He, Baylor College of Medicine, United States; Penghua Yang, University of Maryland, United States</p></fn>
<corresp content-type="corresp" id="cor1">&#x0002A;Correspondence: Guoshun Wang, <email>gwang&#x00040;lsuhsc.edu</email></corresp>
<fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>661</elocation-id>
<history>
<date date-type="received">
<day>08</day>
<month>04</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>05</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Ng, Jennings, Wang, Molina, Nelson and Wang.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Ng, Jennings, Wang, Molina, Nelson and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Acute alcohol exposure suppresses cell inflammatory response. The underlying mechanism has not been fully defined. Here we report that alcohol was able to activate glucocorticoid receptor (GR) signaling in the absence of glucocorticoids (GCs) and upregulated glucocorticoid-induced leucine zipper (<italic>gilz</italic>), a prominent GC-responsive gene. Such a non-canonical activation of GR was not blocked by mifepristone, a potent GC competitor. The proximal promoter of <italic>gilz</italic>, encompassing five GC-responsive elements (GREs), was incorporated and tested in a luciferase reporter system. Deletion and/or mutation of the GREs abrogated the promoter responsiveness to alcohol. Thus, the GR&#x02013;GRE interaction transduced the alcohol action on <italic>gilz</italic>. Alcohol induced GR nuclear translocation, which was enhanced by the alcohol dehydrogenase inhibitor fomepizole, suggesting that it was alcohol, not its metabolites, that engendered the effect. Gel mobility shift assay showed that unliganded GR was able to bind GREs and such interaction withstood clinically relevant levels of alcohol. GR knockout <italic>via</italic> CRISPR/Cas9 gene targeting or GILZ depletion <italic>via</italic> small RNA interference diminished alcohol suppression of cell inflammatory response to LPS. Thus, a previously unrecognized, non-canonical GR activation of <italic>gilz</italic> is involved in alcohol modulation of cell immune response.</p>
</abstract>
<kwd-group>
<kwd>glucocorticoid receptor</kwd>
<kwd>glucocorticoid-induced leucine zipper</kwd>
<kwd>glucocorticoid</kwd>
<kwd>alcohol</kwd>
<kwd>LPS</kwd>
<kwd>inflammatory response</kwd>
</kwd-group>
<contract-num rid="cn01">R21AA021824, R21AA024549, P60AA09803</contract-num>
<contract-sponsor id="cn01">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></contract-sponsor>
<counts>
<fig-count count="7"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="61"/>
<page-count count="11"/>
<word-count count="7628"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p>Ethanol, commonly referred to alcohol in everyday life, is the intoxicating ingredient found in beer, wine, and liquor. Alcohol is one of the most consumed substances and affects human health positively or negatively depending on how it is used. Moderate alcohol intake reduces the risk of many adverse health conditions including coronary artery disease, diabetes, hypertension, congestive heart failure, stroke, arthritis, and dementia (<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B3">3</xref>). However, alcohol abuse is linked to organ and tissue damage (<xref ref-type="bibr" rid="B3">3</xref>&#x02013;<xref ref-type="bibr" rid="B5">5</xref>), which often leads to life-threatening medical complications (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Alcohol has long been recognized as a potent immunosuppressive agent that predisposes individuals to infections by bacteria, fungi, and viruses (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B8">8</xref>&#x02013;<xref ref-type="bibr" rid="B11">11</xref>) and leads to specific defects in innate and adaptive immunity (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>The hypothalamic&#x02013;pituitary&#x02013;adrenal (HPA) axis is a major regulatory system of host immunity, which is accomplished by adrenal production of glucocorticoids (GCs) (<xref ref-type="bibr" rid="B13">13</xref>). GCs act through intracellular interaction with glucocorticoid receptor (GR), a ligand-dependent transcriptional factor that belongs to the superfamily of steroid/thyroid/retinoic acid receptor proteins (<xref ref-type="bibr" rid="B14">14</xref>&#x02013;<xref ref-type="bibr" rid="B16">16</xref>). GR signaling is crucial to modulating host immunity. Clinically, steroid therapy is the most prescribed medication for treating chronic inflammatory conditions and autoimmune diseases (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>) and animals with conditional GR-knockout succumb to LPS-induced septic shock (<xref ref-type="bibr" rid="B19">19</xref>). GR consists of an amino-terminal transactivation domain, a central DNA-binding domain, and a carboxy-terminus containing the hormone-binding domain as well as sequences related to nuclear translocation, receptor dimerization, and interaction with other cellular proteins (<xref ref-type="bibr" rid="B20">20</xref>). In the absence of ligands, GR is sequestered in the cytoplasm by various accessory proteins, including hsp90, hsp70, hsp56, p23, and immunophilins (<xref ref-type="bibr" rid="B21">21</xref>). Upon hormonal binding, the receptor undergoes a conformational change and translocates into the cell nucleus where it binds to GC-responsive elements (GREs) in the promoters of GR-targeting genes (<xref ref-type="bibr" rid="B22">22</xref>) or tethers with other protein factors (<xref ref-type="bibr" rid="B23">23</xref>). Among the GR-targeting genes, Glucocorticoid-induced leucine zipper (GILZ) is a member of the transforming growth factor-beta (TGF-&#x003B2;)-stimulated clone-22 (TSC-22) family of transcription factors (<xref ref-type="bibr" rid="B24">24</xref>). Direct evidence for the role of GILZ in host immune suppression comes from the naturally evolved inbred SPRET/Ei mice, which are resistant to LPS-induced endotoxemia as a result of an intrinsically increased production of GILZ due to a genetic variation (<xref ref-type="bibr" rid="B25">25</xref>). Macrophages with GILZ-knockout lose their LPS tolerance (<xref ref-type="bibr" rid="B26">26</xref>). GILZ is reported to transduce the anti-inflammatory action of GCs in epithelial cells (<xref ref-type="bibr" rid="B27">27</xref>) and redirects the maturation of human dendritic cells to prevent antigen-specific T lymphocyte response (<xref ref-type="bibr" rid="B28">28</xref>). Transgenic mice overexpressing GILZ downregulate the Th-1 and upregulate the Th-2 responses (<xref ref-type="bibr" rid="B29">29</xref>&#x02013;<xref ref-type="bibr" rid="B31">31</xref>). All these data implicate GILZ as a key player in host anti-inflammation and immunosuppression (<xref ref-type="bibr" rid="B31">31</xref>&#x02013;<xref ref-type="bibr" rid="B33">33</xref>).</p>
<p>Alcohol was reported to elevate plasma GC concentration at the physiological level (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>), which activates GR signaling through the conventional GC&#x02013;GR interaction. However, whether alcohol has direct impact on GR signaling at the cellular level is unknown. An early study by Mandrekar and colleagues demonstrated that acute alcohol increases nuclear translocation of non-ligand-bound GR (<xref ref-type="bibr" rid="B36">36</xref>). However, whether this unliganded GR has any biological significance was not defined in that study. Our genome-wide analysis of alcohol influence of gene expression demonstrated that acute alcohol upregulates a cluster of GC-responsive genes in a dose-dependent manner (<xref ref-type="bibr" rid="B37">37</xref>), including GILZ (TSC22D3) (<xref ref-type="bibr" rid="B31">31</xref>), ALOX15B (<xref ref-type="bibr" rid="B38">38</xref>), SYNPO2 (<xref ref-type="bibr" rid="B39">39</xref>), and PTEN (<xref ref-type="bibr" rid="B40">40</xref>), implying that the alcohol-induced non-ligand-bound GR is biologically functional. The current study was designed to delineate the mechanism underlying how alcohol influences GR signaling and activates GC-responsive genes, such as GILZ, in the absence of GC ligands.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2-1">
<title>Chemicals and Reagents</title>
<p>Common reagents were from Sigma-Aldrich (St. Louis, MO, USA). Alcohol or ethanol (200 proof, absolute ACS/USP Grade) was purchased from Pharmco Products Inc. (Shelbyville, KY, USA). Radioactive &#x003B3;-<sup>32</sup>P-ATP was obtained from Perkin Elmer (Billerica, MA, USA). All oligonucleotides were ordered from Integrated DNA Technologies (Coralville, IA, USA) and their sequences are displayed in Table <xref ref-type="table" rid="T1">1</xref>.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Oligonucleotides used in experiments.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Name</th>
<th valign="top" align="left">Oligonucleotide sequence</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">GILZ-F</td>
<td align="left" valign="top">5&#x02032;-CATGGAGGTGGCGGTCTATC-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">GILZ-R</td>
<td align="left" valign="top">5&#x02032;-CACCTCCTCTCTCACAGCGT-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Long-GILZp-F</td>
<td align="left" valign="top">5&#x02032;-CGGGGTACGTGCAGAGGGCAAATTAATA-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Short-GILZp-F</td>
<td align="left" valign="top">5&#x02032;-GGGAATTCTGATACCGGCATAACTGCCCTG-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">GILZp-R</td>
<td align="left" valign="top">5&#x02032;-CCCAAGCTTCGCAGTCCAACCCAGACTC-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Mut-GRE1-F</td>
<td align="left" valign="top">5&#x02032;-CAAACTAGCGCCAGGTCTTACTGAATGCCC-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Mut-GRE1-R</td>
<td align="left" valign="top">5&#x02032;-GGGCATTCAGTAAGACCTGGCGCTAGTTTG-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Mut-GRE2-F</td>
<td align="left" valign="top">5&#x02032;-GGTGGAACCCAAGAGCACCCTTTGGTCCTG-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Mut-GRE2-R</td>
<td align="left" valign="top">5&#x02032;-CAGGACCAAAGGGTGCTCTTGGGTTCCACC-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Wt-GRE1(&#x0002B;)</td>
<td align="left" valign="top">5&#x02032;-CAAACTAGCGCTGTTCTTTACTGAATGCCC-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Wt-GRE1(&#x02212;)</td>
<td align="left" valign="top">5&#x02032;-GGGCATTCAGTAAAGAACAGCGCTAGTTTG-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Mut-GRE1(&#x0002B;)</td>
<td align="left" valign="top">5&#x02032;-CAAACTAGCGCCAGGTCTTTACTGAATGCCC-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Mut-GRE1(&#x02212;)</td>
<td align="left" valign="top">5&#x02032;-GGGCATTCAGTAAAGACCTGGCGCTAGTTTG-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Wt-GRE2(&#x0002B;)</td>
<td align="left" valign="top">5&#x02032;-GGTGGAACCCAATGTTCTCCTTTGGTCCTG-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Wt-GRE2(&#x02212;)</td>
<td align="left" valign="top">5&#x02032;-CAGGACCAAAGGAGAACATTGGGTTCCACC-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Mut-GRE2(&#x0002B;)</td>
<td align="left" valign="top">5&#x02032;-GGTGGAACCCAAGAGCACCCTTTGGTCCTG-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">Mut-GRE2(&#x02212;)</td>
<td align="left" valign="top">5&#x02032;-CAGGACCAAAGGGTGCTCTTGGGTTCCACC-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">GR-E3 (&#x0002B;)</td>
<td align="left" valign="top">5&#x02032;-GAGTTCACTGTGAGCATTC-3&#x02032;</td>
</tr>
<tr>
<td align="left" valign="top">GR-E3 (&#x02212;)</td>
<td align="left" valign="top">5&#x02032;-GAGGGTAAGGATCAGGTCTTATTG-3&#x02032;</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="S2-2">
<title>Cell Culture and Alcohol Exposure</title>
<p>A549 and Mono Mac 6 (MM6) cells were, respectively, cultured in Dulbecco&#x02019;s Modified Eagle Medium (Gibco) and advanced RPMI-1640 (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) (HyClone, Logan, UT, USA), 2&#x02009;mM GlutaMax (Gibco), 100 U/ml penicillin, 100&#x02009;&#x000B5;g/ml streptomycin, and 0.25&#x02009;&#x000B5;g/ml amphotericin B. Forty-eight hours before and during experiments, fresh media with 10% charcoal-stripped FBS (Atlanta Biological) were used to avoid GC interference in experiments. For alcohol exposure, various doses (0, 25, or 50&#x02009;mM) of alcohol were added to the culture media, respectively, and the cells were cultured in the incubators presaturated with the corresponding levels of alcohol.</p>
</sec>
<sec id="S2-3">
<title>MM6 Cell Treatments and RT-qPCR for Gilz Expression</title>
<p>MM6 cells (1.5&#x02009;&#x000D7;&#x02009;10<sup>6</sup>) were exposed to alcohol (0, 25, or 50&#x02009;mM) or 1&#x02009;&#x000B5;M Dexamethasone (Dex) (Sigma-Aldrich) for 24&#x02009;h in the presence or absence of 5&#x02009;&#x000B5;M mifepristone (Sigma-Aldrich). The cells were harvested and washed with 1&#x000D7; PBS twice. Total RNAs were extracted using the Qiagen RNeasy Kit. The cDNAs were synthesized using the Quantitect Reverse Transcriptase Kit (Qiagen). Human GILZ primers (GILZ-F and GILZ-R) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) primers (GAPDH-F and GAPDH-R) were used at a final concentration of 500&#x02009;nM. The final reaction for each sample was brought to a total volume of 20&#x02009;&#x000B5;l with RT SYBR green qPCR mastermixes (Qiagen). All reactions were carried out in duplicate on a CFX96 system (Bio-Rad Laboratories, Hercules, CA, USA) for quantitative real-time PCR (qPCR) detection. The qPCR data were analyzed by the comparative Ct (&#x00394;&#x00394;CT) method. The expression of GILZ of each treated group was compared to that of GAPDH and normalized to the non-treatment group.</p>
</sec>
<sec id="S2-4">
<title>Luciferase Plasmid Construction</title>
<p>The <italic>gilz</italic> promoter was PCR-amplified from the genomic DNA of primary human airway epithelial cells (Lonza Walkersville, Inc., Walkersville, MA, USA) using the primers (Long-GILZp-F and GILZp-R). The amplicon was cloned into pCR&#x02122;-Blunt II-TOPO<sup>&#x000AE;</sup> plasmid (Invitrogen), and the primary sequence was verified by DNA sequencing. Then, the obtained 1.94-Kb promoter was excised with <italic>Kpn</italic>I/<italic>Hin</italic>dIII and subcloned into the promoter-less pGL.4.16[<italic>luc2CP/</italic>Hygro] plasmid (Promega, Madison, WI, USA), resulting in pGL.4.16-wtGILZ-2p-[<italic>luc2CP/</italic>Hygro] in which the GILZ promoter drives the expression of the rapid-response <italic>firefly</italic> luciferase (Fluc) gene. The cloned promoter contains five GREs. To remove GRE3-5, the region (&#x02212;1,560 to &#x02212;1,884) was deleted using the primers (Short-GILZp-F and GILZp-R). To achieve site-specific mutagenesis of the GRE1 and GRE2 core sequences, QuikChange II Site-Directed Mutagenesis Kit (Agilent Technologies) was used, as instructed by the manufacturer. Synthetic oligonucleotide primers (Mut-GRE1-F, Mut-GRE1-R, Mut-GRE2-F, and Mut-GRE2-R) were used to introduce mutations. All the plasmids with mutagenesis were verified by DNA sequencing.</p>
</sec>
<sec id="S2-5">
<title>Dual-Luciferase Reporter Assay</title>
<p>Transfection was performed with Lipofectamine 2000 Transfection Reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer&#x02019;s instruction. Each of the constructed plasmids was cotransfected into A549 cells with the reference plasmid pGL4.73[hRluc/SV40] (Promega) that expresses <italic>Renilla</italic> luciferase. Forty-eight hours later, the transfected cells were exposed to 0 or 50&#x02009;mM of alcohol or 1&#x02009;&#x000B5;M Dex for 24&#x02009;h. Activities of <italic>Firefly</italic> luciferase and <italic>Renilla</italic> luciferase were measured using the dual luciferase assay system (Promega). Potency of the wild-type or mutant <italic>gilz</italic> promoter to drive the reporter luciferase expression was determined by ratio of the activity of <italic>Firefly</italic> luciferase over that of <italic>Renilla</italic> luciferase.</p>
</sec>
<sec id="S2-6">
<title>Gel Mobility Shift Assay (GMSA)</title>
<p>Double-stranded oligonucleotides for GRE1 and its flanking region and for GRE2 and its flanking region were prepared and end-labeled with <sup>32</sup>P using T4 polynucleotide kinase. GMSA was performed by incubation of recombinant human GR protein (40&#x02009;ng or 0.5&#x02009;pmol) (Sigma-Aldrich), <sup>32</sup>P-labeled oligonucleotides (0.5&#x02009;ng or 0.05&#x02009;pmol) and 1&#x02009;&#x000B5;g poly-deoxyinosinic-deoxycytidylic acid (Sigma-Aldrich), in a final volume of 25&#x02009;&#x000B5;l for each reaction. The GR-GRE complex was resolved by non-denature polyacrylamide gel electrophoresis and detected by X-ray film exposure.</p>
</sec>
<sec id="S2-7">
<title>GILZ Knockdown in MM6 Cells</title>
<p>Lentiviral vectors expressing either siGILZ or siCNTL transgene were constructed as previously described (<xref ref-type="bibr" rid="B37">37</xref>) and were produced <italic>via</italic> triple-plasmid cotransfection of HEK 293T cells (<xref ref-type="bibr" rid="B41">41</xref>). Transduction of MM6 cells was carried out at MOI of 5 in the presence of Polybrene (Sigma-Aldrich, 8&#x02009;&#x000B5;g/ml). Because the lentiviral vectors had an EGFP marker gene in an independent cassette, each set of vector-transduced cells was sorted through multiple rounds to a pure population.</p>
</sec>
<sec id="S2-8">
<title>GR Knockout <italic>via</italic> CRISPR/Cas9 Gene Targeting</title>
<p>The <italic>S. pyogenes</italic> Cas9 plasmid pSpCas9(BB)-2A-GFP (PX458) (Addgene plasmid &#x00023; 48138) was a gift from Dr. Feng Zhang at the Massachusetts Institute of Technology. A target-specific sgRNA sequence for Exon 3 of human GR gene was identified using the CRISPR MultiTargeter<xref ref-type="fn" rid="fn1"><sup>1</sup></xref> and the Zhang lab target finder<xref ref-type="fn" rid="fn2"><sup>2</sup></xref> online tools. The target sgRNA sequence was cloned into the Cas9 vectors according to the Zhang lab protocol (<xref ref-type="bibr" rid="B42">42</xref>). In brief, two single-stranded DNA oligos were designed for the sgRNA target (oligo 1: 5&#x02032;-CACCGCATTAT-GGAGTCTTAACTTG-3&#x02032;; oligo 2: 5&#x02032;-AAACCAAGTTAAGACTCCATAATGC-3&#x02032;). The pair of oligos was phosphorylated and annealed with T4 Polynucleotide Kinase (NEB). The Cas9 plasmids were digested with <italic>Bbs</italic>I (NEB) and then ligated with the annealed oligos using NEB Quick Ligase. The final constructed plasmids were sequenced for verification. MM6 cells (1.4&#x02009;&#x000D7;&#x02009;10<sup>6</sup>) in 300&#x02009;&#x000B5;l of RPMI 1640 media were combined with 20&#x02009;&#x000B5;g of Cas9-GFP-GR plasmid, incubated on ice for 20&#x02009;min and electroporated <italic>via</italic> exponential decay pulse (200&#x02009;V, 975&#x02009;&#x003BC;F) using a Bio-Rad Gene Pulser Xcell system. Following electroporation, cells were incubated on ice again for 20&#x02009;min and cultured in complete RPMI 1640 overnight. Then, the cells were sorted for GFP-positive population using FACS. The sorted cells were plated on 96-well culture plates at single-cell density. After 7&#x02013;14&#x02009;days of growth, cell clones were screened by PCR using GR-E3(&#x0002B;) and GR-E3(&#x02212;) primers and DNA sequencing to confirm GR gene knockout.</p>
</sec>
<sec id="S2-9">
<title>Western Blot Assay</title>
<p>For nuclear GR measurement, MM6 cells were exposed to alcohol (0 or 50&#x02009;mM) or Dex (1&#x02009;&#x000B5;M) for 24&#x02009;h in the presence or absence of fomepizole (4&#x02009;&#x000B5;M). The cell nuclei were isolated using Thermo Scientific&#x02122; NE-PER&#x02122; Nuclear and Cytoplasmic Extraction Reagents in accordance with the manufacturer&#x02019;s instruction. The samples were then subjected to Western blot. Rabbit polyclonal antibodies against human GR (Santa Crus Technology, Santa Cruz, CA, USA) and Histone H3 (Cell Signaling Technology, Danvers, MA, USA) were used. Intensities of the GR and Histone H3 bands were estimated by densitometry using NIH Image-J system.</p>
<p>For GILZ measurement, parental MM6, siCNTL-MM6, and siGILZ-MM6 cells were, respectively, treated with 0 or 1&#x02009;&#x000B5;M Dex for 24&#x02009;h. Cells were collected, harvested, and lysed with 1&#x000D7; RIPA buffer (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 1&#x000D7; protease inhibitor cocktail (Roche, Indianapolis, IN, USA). The cell lysates were collected and subjected to BCA protein assay (Thermo Fisher Scientific, Waltham, MA, USA) for protein concentration. Proteins (50&#x02009;&#x000B5;g) from each sample were loaded onto 10&#x02013;20% Tris&#x02013;Tricine precast gel (Bio-Rad, Hercules, CA, USA) in the Mini-Protein system (Bio-Rad) for electrophoresis. Rabbit polyclonal anti-human GILZ antibody at 1:200 final dilution (FL-134, Santa Cruz Biotechnology) and rabbit anti-&#x003B2;-Actin antibody at 1:5,000 final dilution (Cell Signaling Technology, Danvers, MA, USA) were used to probe GILZ and actin.</p>
</sec>
<sec id="S2-10">
<title>LPS Stimulation and TNF-&#x003B1; Measurement</title>
<p>Different genotypes of MM6 cells, as indicated in each experiment, were exposed to alcohol (0 or 50&#x02009;mM) 1&#x02009;h before stimulation with 100 or 1,000&#x02009;ng/ml LPS from <italic>Escherichia coli</italic> 0111:B4 (Sigma-Aldrich). The supernatants were collected at different time points. TNF-&#x003B1; was measured by ELISA (R&#x00026;D Systems) following the manufacturer&#x02019;s recommendations.</p>
</sec>
<sec id="S2-11">
<title>Statistical Analysis</title>
<p>Statistical analysis was performed with Prism 7.0 (GraphPad Software, La Jolla, CA, USA). A 2-tailed, unpaired Student&#x02019;s <italic>t</italic>-test was used for statistical comparisons. All the data are expressed as mean&#x02009;&#x000B1;&#x02009;SD. Difference with <italic>p</italic>-value smaller than 0.05 is considered statistically significant.</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3-1">
<title>Alcohol Activates GR Signaling <italic>via</italic> a Non-Canonical Mechanism</title>
<p>Classical activation of GR signaling is initiated by GC binding to GR that resides in the cytoplasm in complex with various chaperone proteins. Then, GR undergoes a conformational change, dissociates from the complex, and translocates to the nucleus to modulate gene transcription (<xref ref-type="bibr" rid="B43">43</xref>). However, our previously published data demonstrated that alcohol upregulates <italic>gilz</italic>, a prominent GC-responsive gene, in the absence of GC (<xref ref-type="bibr" rid="B37">37</xref>), suggesting an alternative GR-activation mechanism under alcohol exposure. To delineate the mechanism, we exposed MM6 cells to various concentrations of alcohol (0, 25, or 50&#x02009;mM) or dexamethasone (Dex, 1&#x02009;&#x000B5;M) for 24&#x02009;h in the presence or absence of the GC competitor mifepristone (5&#x02009;&#x000B5;M). Transcription of <italic>gilz</italic> was assessed by quantitative real-time-PCR. As shown in Figure <xref ref-type="fig" rid="F1">1</xref>, alcohol (50&#x02009;mM) significantly upregulated <italic>gilz</italic> by &#x0007E;2-fold. Dex increased <italic>gilz</italic> expression by &#x0007E;27-fold. Importantly, mifepristone completely blocked Dex-activation of <italic>gilz</italic>, but had no effect on alcohol-activation of <italic>gilz</italic>. Because Dex is a synthetic GC that activates GR signaling as a GR agonist, while mifepristone a potent competitive GR antagonist, the data indicate that the mechanism for alcohol activation of GR is different from that for GC activation of GR.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Mifepristone blocks dexamethasone- but not alcohol-activation of gilz. MM6 cells were exposed to alcohol (0, 25, or 50&#x02009;mM) or dexamethasone (Dex, 1&#x02009;&#x000B5;M) for 24&#x02009;h in the presence or absence of mifepristone (5&#x02009;&#x000B5;M). GILZ expression from each treatment was measured by quantitative real-time PCR. Changes in GILZ expression were expressed by fold increases as compared to the base level of GILZ in the no treatment control. The data represent at least three independent experiments. The shown <italic>P</italic>-values by Student&#x02019;s <italic>t</italic>-test indicate statistically significant differences. NS denotes non-significant difference.</p></caption>
<graphic xlink:href="fimmu-08-00661-g001.tif"/>
</fig>
</sec>
<sec id="S3-2">
<title>Alcohol Activates Gilz Promoter through GR&#x02013;GRE Interaction</title>
<p>To define the <italic>cis</italic>-acting elements that are responsible for alcohol activation of <italic>gilz</italic>, we cloned the 1.94-kb promoter region of <italic>gilz</italic>. Primary sequence analysis by the CISTER algorithm method (<xref ref-type="bibr" rid="B44">44</xref>) revealed multiple clusters of <italic>cis</italic>-elements, including GRE, cAMP response element (CRE), Forkhead responsive element (FHRE-1), serum response element (SRE), signaling transducer and activator of transcription 6 (STAT-6), GATA Box (GATA), and TATA box (TATA) (Figure S1 in Supplementary Material). Noticeably, there are five GREs, three of which (GRE3, 4, and 5) are relatively distal, and the other two (GRE1 and 2) proximal to the transcriptional initiation site defined by a previous study (<xref ref-type="bibr" rid="B45">45</xref>).</p>
<p>To compare Dex-activation of <italic>gilz</italic> with alcohol activation of <italic>gilz</italic>, we subcloned the 1.94-kb <italic>gilz</italic> promoter into the promoter-less pGL.4.16[<italic>luc2CP/</italic>Hygro] construct, generating the pGL-Long-GILZp-Fluc plasmid (Figure <xref ref-type="fig" rid="F2">2</xref>A), in which the cloned promoter was designed to regulate the expression of the rapid-response <italic>firefly</italic> luciferase (Fluc) gene. Because GRE3, 4, and 5 were located closely, we decided to remove them altogether by deletion of the region (&#x02212;1,560 to &#x02212;1,884), resulting in a shorter <italic>gilz</italic> promoter and the pGL-Short-GILZp-Fluc plasmid. On the basis of this short promoter construct, we further site-mutated the proximal GRE1 and GRE2 core sequences, producing the pGL-Short-mutGILZp-Luc plasmid (Figure <xref ref-type="fig" rid="F2">2</xref>A) that had lost all five GREs. A549 cells were, respectively, transfected with one of the three generated plasmids in combination with the reference plasmid pGL4.75-hRluc that constitutively expressed the humanized <italic>Renilla</italic> luciferase. Forty-eight hours after transfection, the cells were exposed to 0 or 50&#x02009;mM alcohol or 1&#x02009;&#x000B5;M of Dex for 24&#x02009;h. Potency of the wild-type or the mutated <italic>gilz</italic> promoter to drive the reporter gene expression was determined by the activity of the <italic>Firefly</italic> luciferase that had been normalized to that of the <italic>Renilla</italic> luciferase in each sample. The data (Figure <xref ref-type="fig" rid="F2">2</xref>B) demonstrate that the promoter-less pGL.4.16-[<italic>luc2CP/</italic>Hygro] vector (pGL-vector) did not respond to either Dex or alcohol stimulation. However, the long wild-type <italic>gilz</italic> promoter with all five GREs (pGL-Long-GILZp) faithfully responded to Dex and alcohol, displaying &#x0007E;2.3- and &#x0007E;1.6-fold higher <italic>firefly</italic> luciferase activity than the non-treatment control. Deletion of GRE3, 4, and 5 (pGL-Short-GILZp) significantly reduced the <italic>gilz</italic> promoter responsiveness to alcohol but not Dex. Further mutations of GRE1 and GRE2 (pGL-Short-mut-GILZp) totally abolished the responsiveness of the promoter to both Dex and alcohol. These data suggest that alcohol bypasses GC to activate <italic>gilz</italic> promoter through the GRE <italic>cis</italic>-elements, and that all five GREs appear to be needed for a full action of alcohol. In contrast, the GRE1 and GRE2 are sufficient to convey the full effect of Dex.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Alcohol activates GILZ promoter <italic>via</italic> GRE cis-elements. <bold>(A)</bold> The <italic>gilz</italic> promoter was cloned into the promoter-less pGL.4.16[luc2CP/Hygro] construct, generating the pGL-Long-GILZp-Fluc plasmid. GRE3-5 sites were removed by deletion of the region (&#x02212;1,560 to &#x02212;1,884), resulting in the pGL-Short-GILZp-Fluc plasmid. The GRE1 and GRE2 sites were mutated, producing the pGL-Short-mutGILZp-Luc plasmid. <bold>(B)</bold> A549 cells were, respectively, transfected with one of the three resulting plasmids in combination with the reference plasmid pGL4.75-hRluc that constitutively expressed the humanized <italic>Renilla</italic> luciferase. Forty-eight hours after transfection, the cells were exposed to 0 or 50&#x02009;mM alcohol or 1&#x02009;&#x000B5;M of Dex for 24&#x02009;h. Potency of the wild-type or each mutated <italic>gilz</italic> promoter to drive the reporter gene expression was determined by the activity of the <italic>Firefly</italic> luciferase that had been normalized to that of the <italic>Renilla</italic> luciferase in each sample. Asterisks denote significant differences between the comparing groups by Student&#x02019;s <italic>t</italic>-test (&#x0002A;<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.05, &#x0002A;&#x0002A;<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.01; <italic>n</italic>&#x02009;&#x0003D;&#x02009;3).</p></caption>
<graphic xlink:href="fimmu-08-00661-g002.tif"/>
</fig>
</sec>
<sec id="S3-3">
<title>Alcohol Instead of Alcohol Metabolites Enhances GR Nuclear Translocation</title>
<p>Previous publications from our laboratory and others have reported that alcohol induces nuclear translocation of non-ligand-bound GR (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). However, it is unknown whether this effect is caused by alcohol itself or alcohol metabolites. We exposed MM6 cells to alcohol (0 or 50&#x02009;mM) for 24&#x02009;h in the presence or absence of the alcohol dehydrogenase (ADH) inhibitor fomepizole (4&#x02009;&#x000B5;M). The levels of nuclear GR and Histone H3 for each condition were assessed by Western blot assay and densitometry quantification (Figure <xref ref-type="fig" rid="F3">3</xref>A). The ratio of nuclear GR over Histone H3 for each condition was calculated. Data from three separate experiments (Figure <xref ref-type="fig" rid="F3">3</xref>B) show that alcohol exposure increased nuclear GR as compared to that of the non-alcohol control. Strikingly, fomepizole enhanced GR nuclear translocation. Thus, alcohol-induced GR nuclear translocation is likely the effect of alcohol molecules instead of alcohol-derivatives.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Alcohol dehydrogenase (ADH) inhibitor fomepizole enhances GR nuclear translocation. <bold>(A)</bold> Western blots of nuclear GR and Histone H3. MM6 cells were exposed to alcohol (0 or 50&#x02009;mM) or dexamethasone (Dex, 1&#x02009;&#x000B5;M) for 24&#x02009;h in the presence or absence of the ADH inhibitor fomepizole (4&#x02009;&#x000B5;M). Cell nuclei from each treatment were isolated and subjected to Western blot analysis. Histone H3 was also assessed for loading normalization. <bold>(B)</bold> Statistical data from three independent experiments. The intensities of the GR and Histone H3 bands were quantified by densitometry. Ratio of nuclear GR over the corresponding Histone H3 for each treatment was obtained and graphed. Significant difference was judged by Student&#x02019;s <italic>t</italic>-test (<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.01; <italic>n</italic>&#x02009;&#x0003D;&#x02009;3).</p></caption>
<graphic xlink:href="fimmu-08-00661-g003.tif"/>
</fig>
</sec>
<sec id="S3-4">
<title>Unliganded GR Is Able to Bind GREs in the Presence of Clinically Relevant Levels of Alcohol</title>
<p>Alcohol induces GR&#x02013;GRE interaction in the absence of GC, predicting that non-ligand-bound GR can bind GREs. To prove the prediction, we synthesized and radioactively labeled the double-stranded oligonucleotides covering the core and flanking sequences of GRE1 and GRE2 (Figure <xref ref-type="fig" rid="F4">4</xref>A). Similarly, the corresponding core-sequence-mutated GRE1 and GRE2 oligonucleotides were also prepared. GMSA was undertaken by incubation of human GR protein with the radioactive oligonucleotides. Non-denaturing polyacrylamide gel electrophoresis revealed that human GR protein without GC coupling formed a GR&#x02013;GRE complex with the wild-type GRE1 and GRE2 oligonucleotides, but not the mutant counterparts (Figure <xref ref-type="fig" rid="F4">4</xref>B). This result proves that non-ligand-bound GR is able to interact with GRE in the absence of ligands.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Gel mobility shift assay (GMSA). <bold>(A)</bold> Probe sequences. Sequences of the positive strand of Wt-GRE1, Mut-GRE1, Wt-GRE2, and Mut-GRE2 are displayed. <bold>(B)</bold> GR&#x02013;GRE binding. Human recombinant GR protein (40&#x02009;ng, Hu-GR) was incubated with each of the following double-stranded probes: wild-type GRE1 (Wt-GRE1), mutant GRE1 (Mut-GRE1), wild-type GRE2 (Wt-GRE2), or mutant GRE2 (mut-GRE2). After resolving in a 6% polyacrylamide non-denaturing gel, the GR&#x02013;GRE complex was detected by X-ray film exposure. <bold>(C)</bold> Alcohol effect on GR-GRE binding. The GR protein (40&#x02009;ng, Hu-GR) was incubated with the radio-labeled wild-type GRE1 or GRE2 probe in the presence of various concentrations of alcohol (0, 25, 50, or 100&#x02009;mM). GR&#x02013;GRE binding was similarly examined by GMSA.</p></caption>
<graphic xlink:href="fimmu-08-00661-g004.tif"/>
</fig>
<p>We further tested if the interaction between the unliganded-GR and GRE could withstand alcohol at clinically encountered levels. Human GR protein was incubated with the wild-type GRE1 or GRE2 probe in the presence of alcohol (0, 25, 50, or 100&#x02009;mM). GMSA revealed that the non-canonical GR-GRE interaction was strong enough to withstand all the tested levels of alcohol (Figure <xref ref-type="fig" rid="F4">4</xref>C).</p>
</sec>
<sec id="S3-5">
<title>GR Knockout or GILZ Knockdown Diminishes Alcohol Suppression of Cell Inflammatory Response</title>
<p>To test if <italic>gilz</italic> gene activation by alcohol through the GR-GRE interaction has any functional alteration, we created a GR&#x02212;/&#x02212; MM6 cell line by CRISPR/Cas9 gene targeting (Figure <xref ref-type="fig" rid="F5">5</xref>A), in which a 94-bp insertion mutation was made to GR Exon 3 (Figure S2 in Supplementary Material). Such an insertion led to a premature stop of GR translation and a truncated GR (Figure S3 in Supplementary Material). Then, both GR&#x02212;/&#x02212; and GR&#x0002B;/&#x0002B;MM6 cells were exposed to either 0 or 50&#x02009;mM alcohol, followed by LPS challenge. Twenty-four hours after alcohol exposure, the medium from each condition was collected. Because TNF-&#x003B1; is the key hallmark cytokine induced by LPS (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>), we elected to use TNF-&#x003B1; as the representative cytokine to indicate the status of the cell inflammatory response. ELISA measurement of TNF-&#x003B1; revealed that without alcohol exposure, both genotypes of MM6 cells produced comparable levels of TNF-&#x003B1; after LPS stimulation (Figure <xref ref-type="fig" rid="F5">5</xref>B). Alcohol substantially decreased TNF-&#x003B1; production by GR&#x0002B;/&#x0002B; cells as compared to their non-alcohol control. However, the alcohol suppressive effect on GR&#x02212;/&#x02212; cells was significantly attenuated, suggesting GR without ligand coupling is involved in alcohol suppression of cell inflammatory response. To confirm the fidelity of TNF-&#x003B1; in reflecting cell inflammatory response in our experimental system, we were asked to check more inflammatory genes. Toward this end, we checked three more cytokines: IL-1&#x003B2;, IL-6, and IL-10. Like TNF-&#x003B1;, IL-1&#x003B2;, and IL-6 are proinflammatory, while IL-10 is anti-inflammatory. The results demonstrate that alcohol exposure substantially suppressed proinflammatory cytokine (IL-1&#x003B2; and IL-6) production and substantially promoted anti-inflammatory cytokine production by GR&#x0002B;/&#x0002B; cells. Strikingly, such alcohol effects were diminished in GR&#x02212;/&#x02212; cells (Figure S4 in Supplementary Material). These data confirm that TNF-&#x003B1; is a reliable marker to attest inflammatory response in our system and that GR is crucial in alcohol modulation of cell inflammatory response.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Glucocorticoid receptor (GR) knockout in MM6 cells diminishes alcohol suppression of cell inflammatory response to LPS. <bold>(A)</bold> GR gene knockout in MM6 cells. CRISPR/Cas9 gene targeting was used to knockout the GR gene. PCR amplification of the targeted GR Exon 3 and its flanking sequences shows multiple cell clones with wild-type (GR&#x0002B;/&#x0002B;), heterozygote (GR&#x000B1;) and homozygote (GR&#x02212;/&#x02212;). The GR&#x02212;/&#x02212; cell clone has a 94-bp insertion mutation (see Figure S2 in Supplementary Material), which resulted in a truncated GR (see Figure S3 in Supplementary Material). <bold>(B)</bold> GR&#x0002B;/&#x0002B; and GR&#x02212;/&#x02212; MM6 cells (1&#x02009;&#x000D7;&#x02009;10<sup>6</sup>) were exposed to 0 or 50&#x02009;mM alcohol and challenged with or without LPS (1&#x02009;&#x000B5;g/ml) for 24&#x02009;h. The culture media were collected for TNF-&#x003B1; measurement by ELISA. Asterisks denote statistically significant difference (<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.01; <italic>n</italic>&#x02009;&#x0003D;&#x02009;4) by Student&#x02019;s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fimmu-08-00661-g005.tif"/>
</fig>
<p>We further hypothesized that if GR-activation of <italic>gilz</italic> is critical to alcohol suppression of cell inflammatory response, depletion of GILZ should resemble deletion of GR, resulting in abrogation of the alcohol suppressive effect. Taking advantage of the already-made GILZ-knockdown (siGILZ) and control (siCNTL) lentiviral vectors (<xref ref-type="bibr" rid="B37">37</xref>), we transduced MM6 cells and created a pair of stable cell lines with expression of a normal level of GILZ (siCNTL-MM6) or a diminished level of GILZ (siGILZ-MM6). To verify GILZ expression in these cells, we performed Western blot assay on the parental MM6, siCNTL-MM6, and siGILZ-MM6 cells stimulated with or without Dex. Because GILZ is a highly GC-responsive gene, Dex application here was to maximally stimulate GILZ expression for the most stringent test of GILZ knockdown. The data (Figure <xref ref-type="fig" rid="F6">6</xref>A) demonstrate that GILZ (17&#x02009;kDa) was highly induced by Dex (1&#x02009;&#x000B5;M) in the parental MM6 and siCNTL-MM6 cells. However, the siGILZ-MM6 cells failed to express any detectable level of GILZ, regardless of Dex induction, indicating that the siRNA effectively eradicates GILZ expression in the GILZ-depleted cells.</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>GILZ depletion abrogates alcohol suppression of cell inflammatory response to LPS. MM6 cells were transduced with either the GILZ-knockdown (siGILZ) or the control (siCNTL) lentiviral vector to obtain the stable cell lines with normal GILZ (siCNTL-MM6) or abolished GILZ (siGILZ-MM6) expression. <bold>(A)</bold> Western blot assay to measure GILZ expression. Parental MM6, siCNTL-MM6, and siGILZ-MM6 cells were stimulated with or without Dex (1&#x02009;&#x000B5;M). The 17-kD GILZ expressions induced by Dex in the parental MM6 and the siCNTL-MM6 cells were examined. Western blot for actin was to show equal loading of all samples. <bold>(B)</bold> GILZ and cell immune response to LPS. Parental MM6, siCNTL-MM6, and siGILZ-MM6 cells were exposed to 0 or 50&#x02009;mM alcohol, respectively, followed by a challenge with LPS at either 100&#x02009;ng/ml or 1&#x02009;&#x000B5;g/ml dose. Twenty-four hours after alcohol exposure, the culture media were collected for measurement of inflammatory cytokine TNF-&#x003B1;. Double asterisks denote significant differences between groups by Student&#x02019;s <italic>t</italic>-test (<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.01; <italic>n</italic>&#x02009;&#x0003D;&#x02009;3).</p></caption>
<graphic xlink:href="fimmu-08-00661-g006.tif"/>
</fig>
<p>To examine whether GILZ depletion in the MM6 cells affects alcohol suppression of the cell inflammatory response, we exposed the parental MM6, siCNTL-MM6, and siGILZ-MM6 cells to 0 or 50&#x02009;mM alcohol, respectively, 1&#x02009;h before challenge with LPS at either 100&#x02009;ng/ml or 1&#x02009;&#x000B5;g/ml dose. Twenty-four hours after alcohol exposure, the medium from each condition was collected for TNF-&#x003B1; measurement. As shown (Figure <xref ref-type="fig" rid="F6">6</xref>B), all three types of cells responded to LPS by producing abundant TNF-&#x003B1; in a LPS dose-dependent fashion. Interestingly, GILZ depletion rendered the siGILZ-MM6 cells more inflammatory, producing more TNF-&#x003B1; as compared to the parental MM6 and siCNTL-MM6 cells under an equal level of stimulation. Alcohol exposure at 50&#x02009;mM substantially suppressed TNF-&#x003B1; production by the parental MM6 and siCNTL-MM6 cells. However, the alcohol-suppressive effect was abolished in the GILZ-depleted cells (siGILZ-MM6), suggesting that GILZ is the major player involved in alcohol suppression of cell inflammatory response to LPS.</p>
</sec>
<sec id="S3-6">
<title>A Proposed Model for Alcohol Activation of GR Signaling</title>
<p>Based on the obtained data, we put forward a working model for alcohol activation of GR signaling, as displayed (Figure <xref ref-type="fig" rid="F7">7</xref>). Conventional GC-activation of GR signaling starts from GR binding by GC ligands, e.g., cortisol. The GR&#x02013;GC interaction unleashes GR from the confines of chaperone proteins, such as various heat-shock proteins (HSPs), p23, and others. Then, the GC-coupled GR migrates to the cell nucleus to modulate the expressions of GC-responsive genes. In contrast, alcohol interferes with the stability of the GR complex, from which the unliganded GR is released. Such a non-ligand-bound GR is able to interact with GREs in the promoters of GR-targeting genes including <italic>gilz</italic>. As compared to the conventional GR activation, the alcohol-triggered GR signaling does not involve GCs. This represents a novel non-canonical mechanism for GR activation by alcohol, which may play a pivotal role in alcohol anti-inflammation and immunosuppression.</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p>A proposed model for alcohol induction of GIlZ gene expression <italic>via</italic> a non-canonical glucocorticoid receptor (GR) transactivation. Left panel: glucocorticoids (GC) activation of GR signaling. Cortisol as a representative for GCs enters the cytoplasm and binds to GR. Such a binding alters the GR configuration and disassembles the GR complex. Then, the GC-coupled GR is translocated into the nucleus to bind GREs for activation of GR-targeting genes, such as <italic>gilz</italic>. Right panel: Alcohol activation of GR signaling. Alcohol enters the cytoplasm causing disassembly of the GR complex. The freed non-ligand-bound GR migrates to the nucleus and binds GREs for activation of GR-targeting genes, such as <italic>gilz</italic>. Heat shock proteins and p23 represent the chaperone proteins in the cytoplasmic GR complex.</p></caption>
<graphic xlink:href="fimmu-08-00661-g007.tif"/>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>Alcohol is chemically defined as any organic compound in which a hydroxyl group (&#x02013;OH) is bound to a carbon atom of an alkyl or substituted alkyl group. Alcohol or ethyl alcohol or ethanol, the active component in all wines and alcoholic beverages, is a simple short-chain alcohol. Even though alcohol is the oldest drug used in medicine and a substance widely consumed for leisure and recreation, mechanistic understanding of its many effects on the human body remains remarkably limited. Alcohol has long been known to be anti-inflammatory and immune-suppressive. Examples include that alcohol reduces the development of destructive rheumatoid arthritis (RA), an autoimmune disease characterized by severe joint inflammation (<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>). Moderate alcohol intake was also inversely associated with the risk of systemic lupus erythematosus (SLE), another autoimmune disease (<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>). Alcohol attenuation of the chronic inflammatory diseases resembles the therapeutic effect of steroids. However, the molecular link between alcohol immunosuppression and steroid immunosuppression has not been clearly defined. To our best knowledge, this report provides the first evidence suggesting that alcohol employs an alternative mechanism to activate GR signaling, which may contribute to the long-observed steroid-like effect of alcohol on cell immune response.</p>
<p>The non-ligand-bound GR, induced by alcohol, interacts with GREs and activates <italic>gilz</italic>, suggesting that the &#x0201C;naked&#x0201D; form of GR has biological activities. This finding presents an exception to the current paradigm that GR has to couple with ligands in order to have transacting capacity. Alcohol is a versatile solvent, miscible with water and with organic solvents. This amphiphilic property grants this molecule the ability to perturb protein&#x02013;protein interactions that are reliant on weak bonds, such as in the GR complex. GR protein without any GC coupling binds GREs specifically (Figure <xref ref-type="fig" rid="F4">4</xref>), indicating that ligand binding is not necessarily required for GR to interact with GREs. This finding predicts the possibility that any reagents or condition that affects the stability of the GR complex might trigger GR signaling without GC. As a matter of fact, elevations of pH and temperature, shear stress, and other circumstances are reported to induce GR nuclear translocation in a ligand-independent manner (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>).</p>
<p>GILZ acts as an endogenous carrier that transmits GC therapeutic actions to achieve anti-inflammation and immunosuppression (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B54">54</xref>&#x02013;<xref ref-type="bibr" rid="B56">56</xref>). GILZ expression is reduced or even absent in various inflammatory disorders, such as chronic rhinosinusitis, Crohn&#x02019;s disease, and atherosclerosis (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). These lines of evidence indicate that suppression of GILZ expression predisposes the host to hyperinflammatory diseases. Contrarily, transgenic expression of GILZ in mice protects the animals from colitis (<xref ref-type="bibr" rid="B59">59</xref>). Exogenous supplement of a GILZ peptide suppresses autoimmune encephalomyelitis (<xref ref-type="bibr" rid="B60">60</xref>). In the current study, we demonstrated that depletion of GILZ in MM6 cells abolished the alcohol suppressive effect on inflammatory cytokine production elicited by LPS challenge. These data suggest that the GR-GILZ pathway is critical to alcohol anti-inflammation and immunosuppression.</p>
<p>It was noticed that the RT-qPCR data (Figure <xref ref-type="fig" rid="F1">1</xref>) demonstrate that Dex stimulated GILZ expression by &#x0007E;27-fold, while the luciferase assay data (Figure <xref ref-type="fig" rid="F2">2</xref>) show that Dex only enhanced luciferase expression by &#x0007E;2.3-fold in the case of GILZ long promoter (pGL-Long-GILZp). Such a disparity could result from the following inequalities: (1) unlike the natural GILZ promoter, the isolated GILZ promoter used to drive luciferase expression is a minimal promoter that lacks all the enhancers; (2) RT-qPCR is a more sensitive detection method than enzymatic assay; and (3) RT-qPCR measures mRNA abundance, while luciferase assay measures luciferase activity. Nevertheless, the two results are consistent even though not directly comparable.</p>
<p>In Figure <xref ref-type="fig" rid="F3">3</xref>, the ADH inhibitor fomepizole was used to inhibit alcohol metabolism. We found that with fomepizole application, significantly more GR nuclear translocation was observed, suggesting that alcohol facilitates such a process. We are aware that there exist multiple alcohol oxidation pathways. The most important pathway is ADH-mediated, as ADHs constitute the dominant enzyme system involved in &#x0007E;80% of alcohol oxidation (<xref ref-type="bibr" rid="B61">61</xref>). The second pathway is through the cytochrome P450 system, also called microsomal alcohol oxidizing system or &#x0201C;MEOS&#x0201D; (mostly CYP2E1), which oxidizes only a small fraction of alcohol in the case of acute alcohol exposure. Future experiments are warranted to define how blocking MEOS affects GR translocation.</p>
<p>As illustrated in the proposed model (Figure <xref ref-type="fig" rid="F7">7</xref>) GR signaling can be activated <italic>via</italic> the canonical ligand binding or the non-canonical alcohol induction. However, the number of GREs required for each activation appears to be different. We found GRE1 and 2 are sufficient to support a full GC activation of <italic>gilz</italic> (Figure <xref ref-type="fig" rid="F2">2</xref>). Nevertheless, all five GREs are needed for a full alcohol activation of <italic>gilz</italic>. It is noteworthy that <italic>in vivo</italic> alcohol exposure may lead to concurrent activations of both pathways. It is unknown how the two GR-activation pathways mutually influence each other, which may collectively define the ultimate outcome of the HPA-GR signal transduction under the condition of alcohol exposure.</p>
<p>In summary, we have demonstrated that alcohol activates GR signaling and <italic>gilz</italic> expression through a non-canonical GR&#x02013;GRE interaction. This GR-activation mechanism contributes to alcohol modulation of cell inflammatory and immune responses.</p>
</sec>
<sec id="S5" sec-type="author-contributor">
<title>Author Contributions</title>
<p>HN conducted the experiments and analyzed the data. JW made lentiviral constructs and performed the RT-qPCR analyses. SJ did GR gene-knockout and established the GR&#x02212;/&#x02212; MM6 cell line. PM and SN provided advice to the project. GW conceived the idea, designed the experiments, and wrote the paper.</p>
</sec>
<sec id="S6">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by NIH grants to GW (R21AA021824 and R21AA024549) and a pilot grant from LSUHSC Comprehensive Alcohol Research Center funded by NIH grant P60AA09803 (SN and PM).</p></fn>
</fn-group>
<sec id="S8" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at <uri xlink:href="http://journal.frontiersin.org/article/10.3389/fimmu.2017.00661/full&#x00023;supplementary-material">http://journal.frontiersin.org/article/10.3389/fimmu.2017.00661/full&#x00023;supplementary-material</uri>.</p>
<supplementary-material xlink:href="Presentation_1.PDF" id="SM1" mimetype="applicationn/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Presentation_2.PDF" id="SM2" mimetype="applicationn/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Presentation_3.PDF" id="SM3" mimetype="applicationn/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Presentation_4.PDF" id="SM4" mimetype="applicationn/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kloner</surname> <given-names>RA</given-names></name> <name><surname>Rezkalla</surname> <given-names>SH</given-names></name></person-group>. <article-title>To drink or not to drink? That is the question</article-title>. <source>Circulation</source> (<year>2007</year>) <volume>116</volume>:<fpage>1306</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.678375</pub-id><pub-id pub-id-type="pmid">17846344</pub-id></citation></ref>
<ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Keefe</surname> <given-names>JH</given-names></name> <name><surname>Bybee</surname> <given-names>KA</given-names></name> <name><surname>Lavie</surname> <given-names>CJ</given-names></name></person-group>. <article-title>Alcohol and cardiovascular health: the razor-sharp double-edged sword</article-title>. <source>J Am Coll Cardiol</source> (<year>2007</year>) <volume>50</volume>:<fpage>1009</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1016/j.jacc.2007.04.089</pub-id><pub-id pub-id-type="pmid">17825708</pub-id></citation></ref>
<ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goral</surname> <given-names>J</given-names></name> <name><surname>Karavitis</surname> <given-names>J</given-names></name> <name><surname>Kovacs</surname> <given-names>EJ</given-names></name></person-group>. <article-title>Exposure-dependent effects of ethanol on the innate immune system</article-title>. <source>Alcohol</source> (<year>2008</year>) <volume>42</volume>:<fpage>237</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1016/j.alcohol.2008.02.003</pub-id><pub-id pub-id-type="pmid">18411007</pub-id></citation></ref>
<ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zakhari</surname> <given-names>S</given-names></name> <name><surname>Li</surname> <given-names>TK</given-names></name></person-group>. <article-title>Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease</article-title>. <source>Hepatology</source> (<year>2007</year>) <volume>46</volume>:<fpage>2032</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1002/hep.22010</pub-id><pub-id pub-id-type="pmid">18046720</pub-id></citation></ref>
<ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Presti</surname> <given-names>RL</given-names></name> <name><surname>Carollo</surname> <given-names>C</given-names></name> <name><surname>Caimi</surname> <given-names>G</given-names></name></person-group>. <article-title>Wine consumption and renal diseases: new perspectives</article-title>. <source>Nutrition</source> (<year>2007</year>) <volume>23</volume>:<fpage>598</fpage>&#x02013;<lpage>602</lpage>.<pub-id pub-id-type="doi">10.1016/j.nut.2007.04.012</pub-id><pub-id pub-id-type="pmid">17574820</pub-id></citation></ref>
<ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>S</given-names></name> <name><surname>Kolls</surname> <given-names>JK</given-names></name></person-group>. <article-title>Alcohol, host defence and society</article-title>. <source>Nat Rev Immunol</source> (<year>2002</year>) <volume>2</volume>:<fpage>205</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nri744</pub-id><pub-id pub-id-type="pmid">11913071</pub-id></citation></ref>
<ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname> <given-names>M</given-names></name> <name><surname>Burnham</surname> <given-names>EL</given-names></name></person-group>. <article-title>Chronic alcohol abuse, acute respiratory distress syndrome, and multiple organ dysfunction</article-title>. <source>Crit Care Med</source> (<year>2003</year>) <volume>31</volume>:<fpage>S207</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1097/01.CCM.0000057845.77458.25</pub-id><pub-id pub-id-type="pmid">12682442</pub-id></citation></ref>
<ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname> <given-names>M</given-names></name> <name><surname>Ewig</surname> <given-names>S</given-names></name> <name><surname>Marcos</surname> <given-names>MA</given-names></name> <name><surname>Martinez</surname> <given-names>JA</given-names></name> <name><surname>Arancibia</surname> <given-names>F</given-names></name> <name><surname>Mensa</surname> <given-names>J</given-names></name> <etal/></person-group> <article-title>Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity</article-title>. <source>Am J Respir Crit Care Med</source> (<year>1999</year>) <volume>160</volume>:<fpage>397</fpage>&#x02013;<lpage>405</lpage>.<pub-id pub-id-type="doi">10.1164/ajrccm.160.2.9808045</pub-id><pub-id pub-id-type="pmid">10430704</pub-id></citation></ref>
<ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zisman</surname> <given-names>DA</given-names></name> <name><surname>Strieter</surname> <given-names>RM</given-names></name> <name><surname>Kunkel</surname> <given-names>SL</given-names></name> <name><surname>Tsai</surname> <given-names>WC</given-names></name> <name><surname>Wilkowski</surname> <given-names>JM</given-names></name> <name><surname>Bucknell</surname> <given-names>KA</given-names></name> <etal/></person-group> <article-title>Ethanol feeding impairs innate immunity and alters the expression of Th1- and Th2-phenotype cytokines in murine <italic>Klebsiella pneumoniae</italic></article-title>. <source>Alcohol Clin Exp Res</source> (<year>1998</year>) <volume>22</volume>:<fpage>621</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1111/j.1530-0277.1998.tb04303.x</pub-id><pub-id pub-id-type="pmid">9622442</pub-id></citation></ref>
<ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szabo</surname> <given-names>G</given-names></name> <name><surname>Dolganiuc</surname> <given-names>A</given-names></name> <name><surname>Dai</surname> <given-names>Q</given-names></name> <name><surname>Pruett</surname> <given-names>SB</given-names></name></person-group>. <article-title>TLR4, ethanol, and lipid rafts: a new mechanism of ethanol action with implications for other receptor-mediated effects</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<fpage>1243</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.3.1243</pub-id><pub-id pub-id-type="pmid">17237368</pub-id></citation></ref>
<ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>P</given-names></name> <name><surname>Bagby</surname> <given-names>GJ</given-names></name> <name><surname>Happel</surname> <given-names>KI</given-names></name> <name><surname>Summer</surname> <given-names>WR</given-names></name> <name><surname>Nelson</surname> <given-names>S</given-names></name></person-group>. <article-title>Pulmonary host defenses and alcohol</article-title>. <source>Front Biosci</source> (<year>2002</year>) <volume>7</volume>:<fpage>d1314</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.2741/A842</pub-id><pub-id pub-id-type="pmid">11991862</pub-id></citation></ref>
<ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>P</given-names></name> <name><surname>Bagby</surname> <given-names>GJ</given-names></name> <name><surname>Happel</surname> <given-names>KI</given-names></name> <name><surname>Raasch</surname> <given-names>CE</given-names></name> <name><surname>Nelson</surname> <given-names>S</given-names></name></person-group>. <article-title>Alcohol abuse, immunosuppression, and pulmonary infection</article-title>. <source>Curr Drug Abuse Rev</source> (<year>2008</year>) <volume>1</volume>:<fpage>56</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.2174/1874473710801010056</pub-id><pub-id pub-id-type="pmid">19630706</pub-id></citation></ref>
<ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>AR</given-names></name> <name><surname>Belvisi</surname> <given-names>MG</given-names></name></person-group>. <article-title>Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor</article-title>. <source>Pharmacol Ther</source> (<year>2012</year>) <volume>134</volume>:<fpage>54</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1016/j.pharmthera.2011.12.004</pub-id><pub-id pub-id-type="pmid">22212616</pub-id></citation></ref>
<ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>RM</given-names></name></person-group>. <article-title>Molecular characterization of the glucocorticoid receptor</article-title>. <source>Recent Prog Horm Res</source> (<year>1989</year>) <volume>45</volume>:<fpage>1</fpage>&#x02013;<lpage>22; discussion 22&#x02013;7</lpage>.</citation></ref>
<ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname> <given-names>C</given-names></name> <name><surname>Hollenberg</surname> <given-names>SM</given-names></name> <name><surname>Ong</surname> <given-names>ES</given-names></name> <name><surname>Harmon</surname> <given-names>JM</given-names></name> <name><surname>Brower</surname> <given-names>ST</given-names></name> <name><surname>Cidlowski</surname> <given-names>J</given-names></name> <etal/></person-group> <article-title>Identification of human glucocorticoid receptor complementary DNA clones by epitope selection</article-title>. <source>Science</source> (<year>1985</year>) <volume>228</volume>:<fpage>740</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="doi">10.1126/science.2581314</pub-id><pub-id pub-id-type="pmid">2581314</pub-id></citation></ref>
<ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname> <given-names>KR</given-names></name></person-group>. <article-title>Steroid receptor regulated transcription of specific genes and gene networks</article-title>. <source>Annu Rev Genet</source> (<year>1985</year>) <volume>19</volume>:<fpage>209</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.genet.19.1.209</pub-id></citation></ref>
<ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Busillo</surname> <given-names>JM</given-names></name> <name><surname>Cidlowski</surname> <given-names>JA</given-names></name></person-group>. <article-title>The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore</article-title>. <source>Trends Endocrinol Metab</source> (<year>2013</year>) <volume>24</volume>:<fpage>109</fpage>&#x02013;<lpage>19</lpage>.<pub-id pub-id-type="doi">10.1016/j.tem.2012.11.005</pub-id><pub-id pub-id-type="pmid">23312823</pub-id></citation></ref>
<ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hillier</surname> <given-names>SG</given-names></name></person-group>. <article-title>Diamonds are forever: the cortisone legacy</article-title>. <source>J Endocrinol</source> (<year>2007</year>) <volume>195</volume>:<fpage>1</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1677/JOE-07-0309</pub-id><pub-id pub-id-type="pmid">17911391</pub-id></citation></ref>
<ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname> <given-names>S</given-names></name> <name><surname>Brown</surname> <given-names>DE</given-names></name> <name><surname>Brewer</surname> <given-names>JA</given-names></name> <name><surname>Vogt</surname> <given-names>SK</given-names></name> <name><surname>Muglia</surname> <given-names>LJ</given-names></name></person-group>. <article-title>Macrophage glucocorticoid receptors regulate toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase</article-title>. <source>Blood</source> (<year>2007</year>) <volume>109</volume>:<fpage>4313</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2006-10-048215</pub-id><pub-id pub-id-type="pmid">17255352</pub-id></citation></ref>
<ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oakley</surname> <given-names>RH</given-names></name> <name><surname>Webster</surname> <given-names>JC</given-names></name> <name><surname>Sar</surname> <given-names>M</given-names></name> <name><surname>Parker</surname> <given-names>CR</given-names> <suffix>Jr</suffix></name> <name><surname>Cidlowski</surname> <given-names>JA</given-names></name></person-group>. <article-title>Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor</article-title>. <source>Endocrinology</source> (<year>1997</year>) <volume>138</volume>:<fpage>5028</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1210/endo.138.11.5501</pub-id><pub-id pub-id-type="pmid">9348235</pub-id></citation></ref>
<ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scheschowitsch</surname> <given-names>K</given-names></name> <name><surname>Leite</surname> <given-names>JA</given-names></name> <name><surname>Assreuy</surname> <given-names>J</given-names></name></person-group>. <article-title>New insights in glucocorticoid receptor signaling-more than just a ligand-binding receptor</article-title>. <source>Front Endocrinol</source> (<year>2017</year>) <volume>8</volume>:<fpage>16</fpage>.<pub-id pub-id-type="doi">10.3389/fendo.2017.00016</pub-id><pub-id pub-id-type="pmid">28220107</pub-id></citation></ref>
<ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Picard</surname> <given-names>D</given-names></name> <name><surname>Yamamoto</surname> <given-names>KR</given-names></name></person-group>. <article-title>Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor</article-title>. <source>EMBO J</source> (<year>1987</year>) <volume>6</volume>:<fpage>3333</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">3123217</pub-id></citation></ref>
<ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Revollo</surname> <given-names>JR</given-names></name> <name><surname>Cidlowski</surname> <given-names>JA</given-names></name></person-group>. <article-title>Mechanisms generating diversity in glucocorticoid receptor signaling</article-title>. <source>Ann N Y Acad Sci</source> (<year>2009</year>) <volume>1179</volume>:<fpage>167</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.04986.x</pub-id><pub-id pub-id-type="pmid">19906239</pub-id></citation></ref>
<ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Adamio</surname> <given-names>F</given-names></name> <name><surname>Zollo</surname> <given-names>O</given-names></name> <name><surname>Moraca</surname> <given-names>R</given-names></name> <name><surname>Ayroldi</surname> <given-names>E</given-names></name> <name><surname>Bruscoli</surname> <given-names>S</given-names></name> <name><surname>Bartoli</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death</article-title>. <source>Immunity</source> (<year>1997</year>) <volume>7</volume>:<fpage>803</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(00)80398-2</pub-id><pub-id pub-id-type="pmid">9430225</pub-id></citation></ref>
<ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinheiro</surname> <given-names>I</given-names></name> <name><surname>Dejager</surname> <given-names>L</given-names></name> <name><surname>Petta</surname> <given-names>I</given-names></name> <name><surname>Vandevyver</surname> <given-names>S</given-names></name> <name><surname>Puimege</surname> <given-names>L</given-names></name> <name><surname>Mahieu</surname> <given-names>T</given-names></name> <etal/></person-group> <article-title>LPS resistance of SPRET/Ei mice is mediated by Gilz, encoded by the Tsc22d3 gene on the X chromosome</article-title>. <source>EMBO Mol Med</source> (<year>2013</year>) <volume>5</volume>:<fpage>456</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1002/emmm.201201683</pub-id><pub-id pub-id-type="pmid">23495141</pub-id></citation></ref>
<ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoppstadter</surname> <given-names>J</given-names></name> <name><surname>Kessler</surname> <given-names>SM</given-names></name> <name><surname>Bruscoli</surname> <given-names>S</given-names></name> <name><surname>Huwer</surname> <given-names>H</given-names></name> <name><surname>Riccardi</surname> <given-names>C</given-names></name> <name><surname>Kiemer</surname> <given-names>AK</given-names></name></person-group>. <article-title>Glucocorticoid-induced leucine zipper: a critical factor in macrophage endotoxin tolerance</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>194</volume>:<fpage>6057</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1403207</pub-id><pub-id pub-id-type="pmid">25964494</pub-id></citation></ref>
<ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eddleston</surname> <given-names>J</given-names></name> <name><surname>Herschbach</surname> <given-names>J</given-names></name> <name><surname>Wagelie-Steffen</surname> <given-names>AL</given-names></name> <name><surname>Christiansen</surname> <given-names>SC</given-names></name> <name><surname>Zuraw</surname> <given-names>BL</given-names></name></person-group>. <article-title>The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells</article-title>. <source>J Allergy Clin Immunol</source> (<year>2007</year>) <volume>119</volume>:<fpage>115</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaci.2006.08.027</pub-id><pub-id pub-id-type="pmid">17208592</pub-id></citation></ref>
<ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>N</given-names></name> <name><surname>Mouly</surname> <given-names>E</given-names></name> <name><surname>Hamdi</surname> <given-names>H</given-names></name> <name><surname>Maillot</surname> <given-names>MC</given-names></name> <name><surname>Pallardy</surname> <given-names>M</given-names></name> <name><surname>Godot</surname> <given-names>V</given-names></name> <etal/></person-group> <article-title>GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response</article-title>. <source>Blood</source> (<year>2006</year>) <volume>107</volume>:<fpage>2037</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2005-07-2760</pub-id><pub-id pub-id-type="pmid">16293609</pub-id></citation></ref>
<ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delfino</surname> <given-names>DV</given-names></name> <name><surname>Agostini</surname> <given-names>M</given-names></name> <name><surname>Spinicelli</surname> <given-names>S</given-names></name> <name><surname>Vacca</surname> <given-names>C</given-names></name> <name><surname>Riccardi</surname> <given-names>C</given-names></name></person-group>. <article-title>Inhibited cell death, NF-kappaB activity and increased IL-10 in TCR-triggered thymocytes of transgenic mice overexpressing the glucocorticoid-induced protein GILZ</article-title>. <source>Int Immunopharmacol</source> (<year>2006</year>) <volume>6</volume>:<fpage>1126</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.intimp.2006.02.001</pub-id><pub-id pub-id-type="pmid">16714216</pub-id></citation></ref>
<ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cannarile</surname> <given-names>L</given-names></name> <name><surname>Fallarino</surname> <given-names>F</given-names></name> <name><surname>Agostini</surname> <given-names>M</given-names></name> <name><surname>Cuzzocrea</surname> <given-names>S</given-names></name> <name><surname>Mazzon</surname> <given-names>E</given-names></name> <name><surname>Vacca</surname> <given-names>C</given-names></name> <etal/></person-group> <article-title>Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines</article-title>. <source>Blood</source> (<year>2006</year>) <volume>107</volume>:<fpage>1039</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2005-05-2183</pub-id><pub-id pub-id-type="pmid">16204313</pub-id></citation></ref>
<ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayroldi</surname> <given-names>E</given-names></name> <name><surname>Riccardi</surname> <given-names>C</given-names></name></person-group>. <article-title>Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action</article-title>. <source>FASEB J</source> (<year>2009</year>) <volume>23</volume>:<fpage>3649</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1096/fj.09-134684</pub-id><pub-id pub-id-type="pmid">19567371</pub-id></citation></ref>
<ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayroldi</surname> <given-names>E</given-names></name> <name><surname>Migliorati</surname> <given-names>G</given-names></name> <name><surname>Bruscoli</surname> <given-names>S</given-names></name> <name><surname>Marchetti</surname> <given-names>C</given-names></name> <name><surname>Zollo</surname> <given-names>O</given-names></name> <name><surname>Cannarile</surname> <given-names>L</given-names></name> <etal/></person-group> <article-title>Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB</article-title>. <source>Blood</source> (<year>2001</year>) <volume>98</volume>:<fpage>743</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1182/blood.V98.3.743</pub-id><pub-id pub-id-type="pmid">11468175</pub-id></citation></ref>
<ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mittelstadt</surname> <given-names>PR</given-names></name> <name><surname>Ashwell</surname> <given-names>JD</given-names></name></person-group>. <article-title>Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ</article-title>. <source>J Biol Chem</source> (<year>2001</year>) <volume>276</volume>:<fpage>29603</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M101522200</pub-id><pub-id pub-id-type="pmid">11397794</pub-id></citation></ref>
<ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname> <given-names>FW</given-names></name></person-group>. <article-title>Effect of ethanol on plasma corticosterone levels</article-title>. <source>J Pharmacol Exp Ther</source> (<year>1966</year>) <volume>153</volume>:<fpage>121</fpage>&#x02013;<lpage>7</lpage>.</citation></ref>
<ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thiagarajan</surname> <given-names>AB</given-names></name> <name><surname>Mefford</surname> <given-names>IN</given-names></name> <name><surname>Eskay</surname> <given-names>RL</given-names></name></person-group>. <article-title>Single-dose ethanol administration activates the hypothalamic-pituitary-adrenal axis: exploration of the mechanism of action</article-title>. <source>Neuroendocrinology</source> (<year>1989</year>) <volume>50</volume>:<fpage>427</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1159/000125259</pub-id><pub-id pub-id-type="pmid">2554177</pub-id></citation></ref>
<ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mandrekar</surname> <given-names>P</given-names></name> <name><surname>Bellerose</surname> <given-names>G</given-names></name> <name><surname>Szabo</surname> <given-names>G</given-names></name></person-group>. <article-title>Inhibition of NF-kappa B binding correlates with increased nuclear glucocorticoid receptor levels in acute alcohol-treated human monocytes</article-title>. <source>Alcohol Clin Exp Res</source> (<year>2002</year>) <volume>26</volume>:<fpage>1872</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.1530-0277.2002.tb02495.x</pub-id><pub-id pub-id-type="pmid">12500112</pub-id></citation></ref>
<ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname> <given-names>M</given-names></name> <name><surname>Raju</surname> <given-names>SV</given-names></name> <name><surname>Viswanathan</surname> <given-names>A</given-names></name> <name><surname>Painter</surname> <given-names>RG</given-names></name> <name><surname>Bonvillain</surname> <given-names>R</given-names></name> <name><surname>Byrne</surname> <given-names>P</given-names></name> <etal/></person-group> <article-title>Ethanol upregulates glucocorticoid-induced leucine zipper expression and modulates cellular inflammatory responses in lung epithelial cells</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>184</volume>:<fpage>5715</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0903521</pub-id><pub-id pub-id-type="pmid">20382889</pub-id></citation></ref>
<ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>Y</given-names></name> <name><surname>Bai</surname> <given-names>X</given-names></name> <name><surname>Yang</surname> <given-names>Q</given-names></name> <name><surname>Wu</surname> <given-names>H</given-names></name> <name><surname>Wang</surname> <given-names>D</given-names></name></person-group>. <article-title>Downregulation of 15-lipoxygenase 2 by glucocorticoid receptor in prostate cancer cells</article-title>. <source>Int J Oncol</source> (<year>2010</year>) <volume>36</volume>:<fpage>1541</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.3892/ijo_00000641</pub-id><pub-id pub-id-type="pmid">20428779</pub-id></citation></ref>
<ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guess</surname> <given-names>A</given-names></name> <name><surname>Agrawal</surname> <given-names>S</given-names></name> <name><surname>Wei</surname> <given-names>CC</given-names></name> <name><surname>Ransom</surname> <given-names>RF</given-names></name> <name><surname>Benndorf</surname> <given-names>R</given-names></name> <name><surname>Smoyer</surname> <given-names>WE</given-names></name></person-group>. <article-title>Dose- and time-dependent glucocorticoid receptor signaling in podocytes</article-title>. <source>Am J Physiol Renal Physiol</source> (<year>2010</year>) <volume>299</volume>:<fpage>F845</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1152/ajprenal.00161.2010</pub-id><pub-id pub-id-type="pmid">20630936</pub-id></citation></ref>
<ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname> <given-names>Z</given-names></name> <name><surname>Tang</surname> <given-names>J</given-names></name> <name><surname>Cai</surname> <given-names>Z</given-names></name> <name><surname>Yang</surname> <given-names>W</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Chen</surname> <given-names>Q</given-names></name> <etal/></person-group> <article-title>A new pathway of glucocorticoid action for asthma treatment through the regulation of PTEN expression</article-title>. <source>Respir Res</source> (<year>2011</year>) <volume>12</volume>:<fpage>47</fpage>.<pub-id pub-id-type="doi">10.1186/1465-9921-12-47</pub-id><pub-id pub-id-type="pmid">21489309</pub-id></citation></ref>
<ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kutner</surname> <given-names>RH</given-names></name> <name><surname>Zhang</surname> <given-names>XY</given-names></name> <name><surname>Reiser</surname> <given-names>J</given-names></name></person-group>. <article-title>Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors</article-title>. <source>Nat Protoc</source> (<year>2009</year>) <volume>4</volume>:<fpage>495</fpage>&#x02013;<lpage>505</lpage>.<pub-id pub-id-type="doi">10.1038/nprot.2009.22</pub-id><pub-id pub-id-type="pmid">19300443</pub-id></citation></ref>
<ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ran</surname> <given-names>FA</given-names></name> <name><surname>Hsu</surname> <given-names>PD</given-names></name> <name><surname>Wright</surname> <given-names>J</given-names></name> <name><surname>Agarwala</surname> <given-names>V</given-names></name> <name><surname>Scott</surname> <given-names>DA</given-names></name> <name><surname>Zhang</surname> <given-names>F</given-names></name></person-group>. <article-title>Genome engineering using the CRISPR-Cas9 system</article-title>. <source>Nat Protoc</source> (<year>2013</year>) <volume>8</volume>:<fpage>2281</fpage>&#x02013;<lpage>308</lpage>.<pub-id pub-id-type="doi">10.1038/nprot.2013.143</pub-id><pub-id pub-id-type="pmid">24157548</pub-id></citation></ref>
<ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hapgood</surname> <given-names>JP</given-names></name> <name><surname>Avenant</surname> <given-names>C</given-names></name> <name><surname>Moliki</surname> <given-names>JM</given-names></name></person-group>. <article-title>Glucocorticoid-independent modulation of GR activity: implications for immunotherapy</article-title>. <source>Pharmacol Ther</source> (<year>2016</year>) <volume>165</volume>:<fpage>93</fpage>&#x02013;<lpage>113</lpage>.<pub-id pub-id-type="doi">10.1016/j.pharmthera.2016.06.002</pub-id><pub-id pub-id-type="pmid">27288728</pub-id></citation></ref>
<ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wingender</surname> <given-names>E</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name> <name><surname>Hehl</surname> <given-names>R</given-names></name> <name><surname>Karas</surname> <given-names>H</given-names></name> <name><surname>Liebich</surname> <given-names>I</given-names></name> <name><surname>Matys</surname> <given-names>V</given-names></name> <etal/></person-group> <article-title>TRANSFAC: an integrated system for gene expression regulation</article-title>. <source>Nucleic Acids Res</source> (<year>2000</year>) <volume>28</volume>:<fpage>316</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1093/nar/28.1.316</pub-id><pub-id pub-id-type="pmid">10592259</pub-id></citation></ref>
<ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asselin-Labat</surname> <given-names>ML</given-names></name> <name><surname>David</surname> <given-names>M</given-names></name> <name><surname>Biola-Vidamment</surname> <given-names>A</given-names></name> <name><surname>Lecoeuche</surname> <given-names>D</given-names></name> <name><surname>Zennaro</surname> <given-names>MC</given-names></name> <name><surname>Bertoglio</surname> <given-names>J</given-names></name> <etal/></person-group> <article-title>GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis</article-title>. <source>Blood</source> (<year>2004</year>) <volume>104</volume>:<fpage>215</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2003-12-4295</pub-id><pub-id pub-id-type="pmid">15031210</pub-id></citation></ref>
<ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rothe</surname> <given-names>J</given-names></name> <name><surname>Lesslauer</surname> <given-names>W</given-names></name> <name><surname>Lotscher</surname> <given-names>H</given-names></name> <name><surname>Lang</surname> <given-names>Y</given-names></name> <name><surname>Koebel</surname> <given-names>P</given-names></name> <name><surname>Kontgen</surname> <given-names>F</given-names></name> <etal/></person-group> <article-title>Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by <italic>Listeria monocytogenes</italic></article-title>. <source>Nature</source> (<year>1993</year>) <volume>364</volume>:<fpage>798</fpage>&#x02013;<lpage>802</lpage>.<pub-id pub-id-type="doi">10.1038/364798a0</pub-id><pub-id pub-id-type="pmid">8395024</pub-id></citation></ref>
<ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tracey</surname> <given-names>KJ</given-names></name> <name><surname>Beutler</surname> <given-names>B</given-names></name> <name><surname>Lowry</surname> <given-names>SF</given-names></name> <name><surname>Merryweather</surname> <given-names>J</given-names></name> <name><surname>Wolpe</surname> <given-names>S</given-names></name> <name><surname>Milsark</surname> <given-names>IW</given-names></name> <etal/></person-group> <article-title>Shock and tissue injury induced by recombinant human cachectin</article-title>. <source>Science</source> (<year>1986</year>) <volume>234</volume>:<fpage>470</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1126/science.3764421</pub-id><pub-id pub-id-type="pmid">3764421</pub-id></citation></ref>
<ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname> <given-names>DR</given-names></name></person-group>. <article-title>Emerging and future therapies for the treatment of bone loss associated with chronic inflammation</article-title>. <source>Inflammopharmacology</source> (<year>2006</year>) <volume>14</volume>:<fpage>193</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1007/s10787-006-0006-1</pub-id><pub-id pub-id-type="pmid">17093901</pub-id></citation></ref>
<ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jonsson</surname> <given-names>IM</given-names></name> <name><surname>Verdrengh</surname> <given-names>M</given-names></name> <name><surname>Brisslert</surname> <given-names>M</given-names></name> <name><surname>Lindblad</surname> <given-names>S</given-names></name> <name><surname>Bokarewa</surname> <given-names>M</given-names></name> <name><surname>Islander</surname> <given-names>U</given-names></name> <etal/></person-group> <article-title>Ethanol prevents development of destructive arthritis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2007</year>) <volume>104</volume>:<fpage>258</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0608620104</pub-id><pub-id pub-id-type="pmid">17185416</pub-id></citation></ref>
<ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bengtsson</surname> <given-names>AA</given-names></name> <name><surname>Rylander</surname> <given-names>L</given-names></name> <name><surname>Hagmar</surname> <given-names>L</given-names></name> <name><surname>Nived</surname> <given-names>O</given-names></name> <name><surname>Sturfelt</surname> <given-names>G</given-names></name></person-group>. <article-title>Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden</article-title>. <source>Rheumatology (Oxford)</source> (<year>2002</year>) <volume>41</volume>:<fpage>563</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1093/rheumatology/41.5.563</pub-id><pub-id pub-id-type="pmid">12011382</pub-id></citation></ref>
<ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname> <given-names>CJ</given-names></name> <name><surname>Palmer</surname> <given-names>BP</given-names></name> <name><surname>Muir</surname> <given-names>KR</given-names></name> <name><surname>Sutton</surname> <given-names>AJ</given-names></name> <name><surname>Powell</surname> <given-names>RJ</given-names></name></person-group>. <article-title>Smoking history, alcohol consumption, and systemic lupus erythematosus: a case-control study</article-title>. <source>Ann Rheum Dis</source> (<year>1998</year>) <volume>57</volume>:<fpage>451</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1136/ard.57.8.451</pub-id><pub-id pub-id-type="pmid">9797548</pub-id></citation></ref>
<ref id="B52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname> <given-names>JY</given-names></name> <name><surname>Jing</surname> <given-names>H</given-names></name> <name><surname>Diamond</surname> <given-names>SL</given-names></name></person-group>. <article-title>Shear stress causes nuclear localization of endothelial glucocorticoid receptor and expression from the GRE promoter</article-title>. <source>Circ Res</source> (<year>2003</year>) <volume>92</volume>:<fpage>279</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1161/01.RES.0000057753.57106.0B</pub-id><pub-id pub-id-type="pmid">12595339</pub-id></citation></ref>
<ref id="B53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname> <given-names>ER</given-names></name></person-group>. <article-title>Heat shock induces translocation to the nucleus of the unliganded glucocorticoid receptor</article-title>. <source>J Biol Chem</source> (<year>1992</year>) <volume>267</volume>:<fpage>17</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">1730584</pub-id></citation></ref>
<ref id="B54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>Q</given-names></name> <name><surname>Morand</surname> <given-names>E</given-names></name> <name><surname>Yang</surname> <given-names>YH</given-names></name></person-group>. <article-title>Development of novel treatment strategies for inflammatory diseases-similarities and divergence between glucocorticoids and GILZ</article-title>. <source>Front Pharmacol</source> (<year>2014</year>) <volume>5</volume>:<fpage>169</fpage>.<pub-id pub-id-type="doi">10.3389/fphar.2014.00169</pub-id><pub-id pub-id-type="pmid">25100999</pub-id></citation></ref>
<ref id="B55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname> <given-names>RT</given-names></name> <name><surname>Hoppstadter</surname> <given-names>J</given-names></name> <name><surname>Hirschfelder</surname> <given-names>K</given-names></name> <name><surname>Hachenthal</surname> <given-names>N</given-names></name> <name><surname>Diesel</surname> <given-names>B</given-names></name> <name><surname>Kessler</surname> <given-names>SM</given-names></name> <etal/></person-group> <article-title>Downregulation of the glucocorticoid-induced leucine zipper (GILZ) promotes vascular inflammation</article-title>. <source>Atherosclerosis</source> (<year>2014</year>) <volume>234</volume>:<fpage>391</fpage>&#x02013;<lpage>400</lpage>.<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2014.03.028</pub-id><pub-id pub-id-type="pmid">24747114</pub-id></citation></ref>
<ref id="B56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoppstadter</surname> <given-names>J</given-names></name> <name><surname>Diesel</surname> <given-names>B</given-names></name> <name><surname>Eifler</surname> <given-names>LK</given-names></name> <name><surname>Schmid</surname> <given-names>T</given-names></name> <name><surname>Brune</surname> <given-names>B</given-names></name> <name><surname>Kiemer</surname> <given-names>AK</given-names></name></person-group>. <article-title>Glucocorticoid-induced leucine zipper is downregulated in human alveolar macrophages upon toll-like receptor activation</article-title>. <source>Eur J Immunol</source> (<year>2012</year>) <volume>42</volume>:<fpage>1282</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201142081</pub-id><pub-id pub-id-type="pmid">22539300</pub-id></citation></ref>
<ref id="B57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berrebi</surname> <given-names>D</given-names></name> <name><surname>Bruscoli</surname> <given-names>S</given-names></name> <name><surname>Cohen</surname> <given-names>N</given-names></name> <name><surname>Foussat</surname> <given-names>A</given-names></name> <name><surname>Migliorati</surname> <given-names>G</given-names></name> <name><surname>Bouchet-Delbos</surname> <given-names>L</given-names></name> <etal/></person-group> <article-title>Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10</article-title>. <source>Blood</source> (<year>2003</year>) <volume>101</volume>:<fpage>729</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2002-02-0538</pub-id><pub-id pub-id-type="pmid">12393603</pub-id></citation></ref>
<ref id="B58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>XH</given-names></name> <name><surname>Lu</surname> <given-names>X</given-names></name> <name><surname>Long</surname> <given-names>XB</given-names></name> <name><surname>You</surname> <given-names>XJ</given-names></name> <name><surname>Gao</surname> <given-names>QX</given-names></name> <name><surname>Cui</surname> <given-names>YH</given-names></name> <etal/></person-group> <article-title>Chronic rhinosinusitis with and without nasal polyps is associated with decreased expression of glucocorticoid-induced leucine zipper</article-title>. <source>Clin Exp Allergy</source> (<year>2009</year>) <volume>39</volume>:<fpage>647</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2222.2008.03198.x</pub-id><pub-id pub-id-type="pmid">19260870</pub-id></citation></ref>
<ref id="B59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cannarile</surname> <given-names>L</given-names></name> <name><surname>Cuzzocrea</surname> <given-names>S</given-names></name> <name><surname>Santucci</surname> <given-names>L</given-names></name> <name><surname>Agostini</surname> <given-names>M</given-names></name> <name><surname>Mazzon</surname> <given-names>E</given-names></name> <name><surname>Esposito</surname> <given-names>E</given-names></name> <etal/></person-group> <article-title>Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis</article-title>. <source>Gastroenterology</source> (<year>2009</year>) <volume>136</volume>:<fpage>530</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2008.09.024</pub-id><pub-id pub-id-type="pmid">18996377</pub-id></citation></ref>
<ref id="B60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname> <given-names>M</given-names></name> <name><surname>Janardhanam</surname> <given-names>S</given-names></name></person-group>. <article-title>Novel p65 binding glucocorticoid-induced leucine zipper peptide suppresses experimental autoimmune encephalomyelitis</article-title>. <source>J Biol Chem</source> (<year>2011</year>) <volume>286</volume>:<fpage>44799</fpage>&#x02013;<lpage>810</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M111.279257</pub-id><pub-id pub-id-type="pmid">21965677</pub-id></citation></ref>
<ref id="B61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beier</surname> <given-names>JI</given-names></name> <name><surname>McClain</surname> <given-names>CJ</given-names></name></person-group>. <article-title>Mechanisms and cell signaling in alcoholic liver disease</article-title>. <source>Biol Chem</source> (<year>2010</year>) <volume>391</volume>:<fpage>1249</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1515/BC.2010.137</pub-id><pub-id pub-id-type="pmid">20868231</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn id="fn1"><p><sup>1</sup><uri xlink:href="http://www.multicrispr.net/">http://www.multicrispr.net/</uri>.</p></fn>
<fn id="fn2"><p><sup>2</sup><uri xlink:href="http://crispr.mit.edu/">http://crispr.mit.edu/</uri>.</p></fn>
</fn-group>
</back>
</article>